Skip to main content
. Author manuscript; available in PMC: 2010 Jun 2.
Published in final edited form as: Proteomics Clin Appl. 2008 Mar 7;2(4):571–584. doi: 10.1002/prca.200780004

Table 3.

Over-expressed proteins in high stage (stage 3/4) ovarian endometrioid tumors

Protein name Access no. Protein MW/pI Observed MW Observed pH range Protein fold-changes Mowse score Sequence coverage (%)
ATP synthase D chain, mitochondrial O75947 18 479/5.21 18 594 5.4–5.2 2.39 6689 72
Tumor protein D53 (hD53) (D52-like 1) Q16890 22 449/5.5 22 464 5.4–5.2 2 2.13E + 05 47
Ras-related protein Rab-14 P61106 23 766/5.8 24 085 5.4–5.2 2.8 1.75E + 04 44
Potassium channel tetramerization domain containing protein 4 Q8WVF5 29 996/7.0 29 979 5.4–5.2 2.9 7037 40
Alkaline phosphatase, tissue-nonspecific isozyme precursor P05186 57 279/6.2 57 240 5.4–5.2 1.3 6.62E + 06 33
T-complex protein 1, theta subunit (TCP-1-theta) P50990 59 621/5.4 59 565 5.6–5.4 2 2.90E + 08 36
Lamin A/C (70 kDa lamin) P02545-2 65 134.8/6.4 65 145 4.8–4.6 1.8 2.93E + 11 48
High-affinity cGMP-specific 3′,5′-cyclic phosphodiesterase 9A O76083 68 493/5.9 68 468 5.4–5.2 7.4 2.58E + 06 33
Baculoviral IAP repeat-containing protein 2 Q13490 69 899.67/6.27 69 844 5.4–5.2 2.3 2.10E + 06 37
Vesicle-fusing ATPase P46459 82 655/6.4 82 717 5.2–5.0 2.1 9.86E + 05 29